<DOC>
	<DOCNO>NCT00296621</DOCNO>
	<brief_summary>The purpose study determine whether long-term oral glutamine supplementation effective improve muscle mass function child Duchenne muscular dystrophy ( DMD ) .</brief_summary>
	<brief_title>Effect Oral Glutamine Muscle Mass Function Duchenne Muscular Dystrophy</brief_title>
	<detailed_description>Glutamine inhibit whole body protein degradation child Duchenne Muscular Dystrophy ( DMD ) . The effect observe 5 h oral glutamine administration also find glutamine give 10-day period . This multi-site national study aim evaluate functional benefit long-term oral glutamine administration 30 DMD child use randomized double-blind placebo-controlled cross-over design . The study include two 4-month period : 1 ) treatment period subject receive oral glutamine ( 0.5 g/kg/d ) 2 ) control period subject receive placebo . The order treatment allocation randomize . The two 4-month period separate 1 month wash-out period . The child monitor every 2 month period 1 ( M0 , M2 , M4 ) period 2 ( M5 , M7 , M9 ) clinical investigation centre Hospital Robert Debr√© Paris CHR &amp; U de Lille , well clinical research centre CHU de Poitiers . Evidence functional benefit would involve evaluate administration glutamine long period ( early possible follow diagnosis ) among severely handicapped child chronic pathology associate increased muscle protein catabolism . In DMD , evidence would enable child undergo gene therapy improve physical condition . Comparisons : Glutamine administration compare placebo follow outcome measure : walk speed standard course , work ( kcal ) power ( kcal/s ) relation effort , body composition ( bioelectrical impedance analysis BIPHOTONIC absorptiometry ) , muscle mass ( 24-h urinary creatinine excretion ) , indices protein degradation ( CPK 3-methyl histidine excretion ) biochemical parameter ( electrolyte , fast glucose , transaminase , insulin , IgfI , Igf-BPI ) .</detailed_description>
	<mesh_term>Muscular Dystrophies</mesh_term>
	<mesh_term>Muscular Dystrophy , Duchenne</mesh_term>
	<criteria>Clinical diagnosis Duchenne muscular dystrophy Able walk &gt; 170 Absence hepatic insufficiency Absence renal insufficiency Dependent upon wheelchair Body weight &gt; 60kg Liver failure Kidney failure Surgery schedule year follow first visit</criteria>
	<gender>Male</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2007</verification_date>
	<keyword>glutamine</keyword>
	<keyword>nutrition</keyword>
	<keyword>child</keyword>
	<keyword>pediatrics</keyword>
	<keyword>randomize control clinical trial</keyword>
	<keyword>therapy</keyword>
	<keyword>supplement</keyword>
	<keyword>oral administration</keyword>
	<keyword>handicap</keyword>
</DOC>